U.S. Sens. Baldwin: Colleagues launch investigation into pharmaceutical companies’ high price of asthma inhalers

WASHINGTON, D.C. – U.S. Senator Tammy Baldwin (D-WI), member of the Senate Committee on Health, Education, Labor, and Pensions (HELP), and three of her colleagues launched an investigation into the extremely high prices four large pharmaceutical companies charge for inhalers that 25 million Americans with asthma and 16 million Americans with chronic obstructive pulmonary disease (COPD) rely ...

Please log in to access subscriber content.
If you don't have a subscription, click here for a WisPolitics free trial and to view the different subscription options.
Facebook
Twitter
LinkedIn

Upcoming Events

Order copies of the 2024 WisPolitics Directory